Posterior Reversible Encephalopathy Syndrome Associated With Anlotinib: A Case Report and Literature Review

Posterior reversible encephalopathy syndrome (PRES) is a relatively rare clinical disease, characterized by reversible subcortical vasogenic edema. Here, we present the first reported case of PRES induced by anlotinib, a multi-target tyrosine kinase inhibitor. A 56-year-old female patient with lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Di, Yin, Xiang, Ma, Di, Jiang, Xiaoyu, Wu, Baihua, Feng, Jiachun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134686/
https://www.ncbi.nlm.nih.gov/pubmed/34025545
http://dx.doi.org/10.3389/fneur.2021.546481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134686/
https://www.ncbi.nlm.nih.gov/pubmed/34025545
http://dx.doi.org/10.3389/fneur.2021.546481

Ejemplares similares